Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Name: Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)
License: Public Domain

Actelion

ClinicalTrials.gov · Datasets · License: Public Domain

pulmonary hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332842
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.